Clinical Trial Update: A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing ddC alone or in combination with AZT versus Zidovudine alone in HIV patients with prior ZDV therapy; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• AZT (zidovudine)
• Dideoxycytidine (ddC) (ddC)
• Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED